icad inc. (NASDAQ:ICAD - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.85 and traded as high as $3.79. icad shares last traded at $3.77, with a volume of 189,085 shares changing hands.
Wall Street Analyst Weigh In
ICAD has been the subject of several research reports. Laidlaw restated a "hold" rating on shares of icad in a research report on Thursday, April 17th. Craig Hallum lowered shares of icad from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 16th. Wall Street Zen assumed coverage on shares of icad in a research report on Tuesday, May 20th. They set a "sell" rating for the company. Finally, BTIG Research cut shares of icad from a "buy" rating to a "neutral" rating in a report on Wednesday, April 16th.
Get Our Latest Research Report on ICAD
icad Price Performance
The firm's fifty day simple moving average is $3.75 and its 200 day simple moving average is $2.90. The company has a market capitalization of $101.92 million, a price-to-earnings ratio of -19.53 and a beta of 1.37.
icad (NASDAQ:ICAD - Get Free Report) last announced its earnings results on Tuesday, May 13th. The technology company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.04. icad had a negative net margin of 26.63% and a negative return on equity of 15.03%. The company had revenue of $4.87 million during the quarter, compared to analysts' expectations of $4.54 million.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. Perritt Capital Management Inc increased its stake in icad by 1.9% in the 4th quarter. Perritt Capital Management Inc now owns 189,100 shares of the technology company's stock valued at $346,000 after buying an additional 3,600 shares during the period. Wells Fargo & Company MN increased its stake in icad by 51.3% in the 4th quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company's stock valued at $72,000 after buying an additional 13,402 shares during the period. Geode Capital Management LLC grew its stake in icad by 6.6% in the fourth quarter. Geode Capital Management LLC now owns 276,493 shares of the technology company's stock valued at $506,000 after purchasing an additional 17,059 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in icad in the first quarter valued at about $40,000. Finally, Goldman Sachs Group Inc. purchased a new position in icad in the first quarter valued at about $44,000. Institutional investors and hedge funds own 24.61% of the company's stock.
About icad
(
Get Free Report)
iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.
Featured Articles
Before you consider icad, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and icad wasn't on the list.
While icad currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
